Annual Current Liabilities
$54.06 M
+$22.08 M+69.05%
December 31, 2024
Summary
- As of March 12, 2025, SYRE annual total current liabilities is $54.06 million, with the most recent change of +$22.08 million (+69.05%) on December 31, 2024.
- During the last 3 years, SYRE annual current liabilities has risen by +$33.92 million (+168.37%).
- SYRE annual current liabilities is now at all-time high.
Performance
SYRE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$54.06 M
-$3.48 M-6.05%
December 31, 2024
Summary
- As of March 12, 2025, SYRE quarterly total current liabilities is $54.06 million, with the most recent change of -$3.48 million (-6.05%) on December 31, 2024.
- Over the past year, SYRE quarterly current liabilities has stayed the same.
- SYRE quarterly current liabilities is now -76.72% below its all-time high of $232.23 million, reached on June 30, 2023.
Performance
SYRE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SYRE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.0% | 0.0% |
| 3 y3 years | +168.4% | +205.8% |
| 5 y5 years | +194.5% | +205.8% |
SYRE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +268.9% | -76.7% | +327.8% |
| 5 y | 5-year | at high | +268.9% | -76.7% | +327.8% |
| alltime | all time | at high | +5009.6% | -76.7% | +5009.6% |
Spyre Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $54.06 M(+69.1%) | $54.06 M(-6.0%) |
| Sep 2024 | - | $57.54 M(+160.1%) |
| Jun 2024 | - | $22.12 M(-48.3%) |
| Mar 2024 | - | $42.82 M(+33.9%) |
| Dec 2023 | $31.98 M(+118.2%) | $31.98 M(-28.7%) |
| Sep 2023 | - | $44.87 M(-80.7%) |
| Jun 2023 | - | $232.23 M(+1737.7%) |
| Mar 2023 | - | $12.64 M(-13.8%) |
| Dec 2022 | $14.66 M(-27.2%) | - |
| Dec 2022 | - | $14.66 M(-17.1%) |
| Sep 2022 | - | $17.68 M(+11.4%) |
| Jun 2022 | - | $15.86 M(-2.7%) |
| Mar 2022 | - | $16.30 M(-19.1%) |
| Dec 2021 | $20.14 M(+22.5%) | $20.14 M(-1.4%) |
| Sep 2021 | - | $20.43 M(-0.9%) |
| Jun 2021 | - | $20.60 M(-36.3%) |
| Mar 2021 | - | $32.37 M(+96.9%) |
| Dec 2020 | $16.44 M(-10.4%) | $16.44 M(+14.6%) |
| Sep 2020 | - | $14.35 M(-9.7%) |
| Jun 2020 | - | $15.89 M(-7.3%) |
| Mar 2020 | - | $17.14 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $18.36 M(+79.3%) | $18.36 M(+19.2%) |
| Sep 2019 | - | $15.40 M(+18.3%) |
| Jun 2019 | - | $13.02 M(+10.3%) |
| Mar 2019 | - | $11.81 M(+15.3%) |
| Dec 2018 | $10.24 M(+81.9%) | $10.24 M(+36.2%) |
| Sep 2018 | - | $7.51 M(+21.7%) |
| Jun 2018 | - | $6.17 M(+7.1%) |
| Mar 2018 | - | $5.76 M(+2.4%) |
| Dec 2017 | $5.63 M(+42.0%) | $5.63 M(+15.4%) |
| Sep 2017 | - | $4.88 M(+10.4%) |
| Jun 2017 | - | $4.42 M(+11.7%) |
| Mar 2017 | - | $3.96 M(-0.2%) |
| Dec 2016 | $3.96 M(+57.2%) | $3.96 M(+3.3%) |
| Sep 2016 | - | $3.84 M(+14.2%) |
| Jun 2016 | - | $3.36 M(-12.0%) |
| Mar 2016 | - | $3.82 M(+51.4%) |
| Dec 2015 | $2.52 M(+138.5%) | $2.52 M(+4.3%) |
| Sep 2015 | - | $2.42 M(-10.4%) |
| Jun 2015 | - | $2.70 M(+127.4%) |
| Mar 2015 | - | $1.19 M(+12.3%) |
| Dec 2014 | $1.06 M(-25.1%) | $1.06 M |
| Dec 2013 | $1.41 M | - |
FAQ
- What is Spyre Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics annual current liabilities year-on-year change?
- What is Spyre Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly current liabilities year-on-year change?
What is Spyre Therapeutics annual total current liabilities?
The current annual current liabilities of SYRE is $54.06 M
What is the all time high annual current liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total current liabilities is $54.06 M
What is Spyre Therapeutics annual current liabilities year-on-year change?
Over the past year, SYRE annual total current liabilities has changed by +$22.08 M (+69.05%)
What is Spyre Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SYRE is $54.06 M
What is the all time high quarterly current liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total current liabilities is $232.23 M
What is Spyre Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SYRE quarterly total current liabilities has changed by $0.00 (0.00%)